Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Deferral review regarding vCJD is ‘ongoing’ – IBTS

By Mindo - 07th Feb 2019 | 19 views

This period covers the epidemic of bovine spongiform encephalopathy (BSE) in cattle in the UK.

In July 2018, the IBTS’s medical advisory committee (MAC) held a “lengthy discussion” on whether the Transfusion Service could remove the permanent deferral.

However, it was “agreed by all” there would be no change at that time, according to meeting minutes seen by the Medical Independent (MI).

This was due to uncertainty surrounding a death in the UK in 2016 from variant Creutzfeldt-Jakob disease (vCJD), the human form of BSE. The deceased man had a different genetic profile to those previously affected, allowing for the possibility of a longer incubation period. 

IBTS Medical and Scientific Director Dr Stephen Field told the meeting it remained uncertain whether the 2016 death, which was the most recently recorded in the UK, represented a “second wave of vCJD” in people with this genetic profile.

The MAC decided that the deferral would be reviewed in 12 months. It also agreed the issue could be revisited earlier if the UK’s Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) made any announcements in the interim.

An IBTS spokesperson told MI: “The vCJD deferral review is ongoing and is expected to take about a year. SaBTO in the UK has not yet published its latest scientific evidence in relation to vCJD… The IBTS will review any reports that are published on the continuing level of risk posed by vCJD and take them into account in making a final decision on whether to change the deferral.”

Currently, the IBTS has a permanent deferral policy in regard to blood donation by people who resided for 12 months or more in Northern Ireland, England, Scotland, Wales, the Channel Islands and the Isle of Man between 1980 and 1996. The 12-month period is accumulated and includes brief trips and weekend visits, for example.

This policy was introduced in 2004 following the first confirmed case of vCJD transmission via blood transfusion in the UK.

Leave a Reply

Latest Issue
The Medical Independent 30th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read